-
Lights out in Laos as electricity exports surge
-
Anthropic details Claude misuse as US targets major illicit online marketplace
-
Steven Strogatz weighs AI mathematics advances and their consequences for researchers
-
Venezuelans outside Caracas say capital not sharing blackout burden
-
Anthropic boss calls for AI slowdown, Altman and Musk agree
-
Anthropic boss calls for slowing pace of AI development
-
French IT giant Capgemini sells subsidiary after row over ICE links
-
BRICS nations urge 'maximum restraint' in Middle East war
-
Quebec Brokerage Qubit Insurance Announces New Data on Coverage Shortfalls as Rebuilding Costs Rise
-
Europe eyes battle over 'pervert' AI glasses
-
Lady Gaga welcomes first child with fiance: US media
-
Children in flood-hit Nepal grapple with loss, cling to hope
-
Bhutan business bets on hazelnuts for farming future
-
Venice Film Festival: A look back on the highlights
-
'Widow's Bay' and 'The Pitt' are favorites for Emmys night
-
DR Congo school fire stampede death toll rises to 26: UNICEF
-
Coastal erosion forces cancellation of California music festival
-
Dance Fitness Tempe Announces Expansion of Accessible Digital Movement Programs
-
Argentina's Dirty War rears its head in Venice film
-
Europe saw record summer air traffic despite Mideast war: Eurocontrol
-
UK lawmakers throw out bill to legalise assisted dying
-
Relatives of 9/11 victims hit out at Saudi Arabia -- and US leaders
-
US inflation steady in August, fueling Fed rate hike expectations
-
Relative of 9/11 victim unleashes searing attack on Saudi Arabia
-
New York marks 25th anniversary of 9/11 attacks
-
Czech antitrust office lets Turkey's Pegasus Airlines buy Smartwings
-
Nepal flood reconstruction bill to be $4.78 bn: foreign ministry
-
Investors on edge as energy costs, surging bond yields roil markets
-
JUMO and Standard Bank launch Social Finance Framework to scale inclusive finance in Africa
-
UK lawmakers to vote again on failed assisted dying bill
-
Doomsday tech: could AI really kill us all?
-
Yemen's Houthis complete takeover of Bab al-Mandab area: govt official to AFP
-
French comedy show 'Call my agent' makes film comeback
-
Fast-pace dance takes I.Coast's working-class streets by storm
-
It's all coming back: Celine Dion fans gear up for Paris return
-
Fans celebrate Celine Dion's Paris return with giant karaoke
-
Researchers eye AI revolution in natural disaster forecasts
-
Appreciation, anger await as Trump heads to Irish golf resort
-
US braces for inflation report that may push Fed to hike rates
-
Putin arrives in India for BRICS summit coloured by wars
-
Musk threatens legal action over documentary
-
Carney says in touch with Trump, Canada ready for 'fair' trade deal
-
Latin America fact-check group asks Meta not to replace verification practice
-
Tag Markets Names Craig Lund Chief Executive Officer
-
AI Risks to Enter 60–80% of Liability and Cyber Insurance Underwriting by 2028, ScienceSoft Predicts
-
ECB lifts borrowing costs amid energy shock, opens door for more hikes
-
Tribal Launches Campfire, Letting Business and Technical Teams Build on Salesforce Together
-
Global Tokenized Real Estate Market to Hit up to $3 Trillion by 2030, ScienceSoft Predicts
-
Stocks fall as fresh oil surge fans inflation fears
-
US producer inflation tops expectations as diesel costs jump
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
Y.Ponomarenko--CPN